{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:27:35Z","timestamp":1788280055031,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Continuous glucose monitoring (CGM) has transformed diabetes management, offering real-time and dynamic insights into glucose variability and addressing the limitations of traditional glucose assessment methods. Kidney transplantation, the most common solid organ transplant, carries a considerable burden of post-transplant diabetes mellitus (PTDM), which is linked to increased cardiovascular events, graft dysfunction, and increased mortality. This review explores the role of CGM in kidney transplant recipients, particularly its impact on glycemic profiles and its predictive value for post-transplant diabetes mellitus (PTDM). At the time of this review, CGM had not yet been incorporated into standard transplant care protocols. Evidence shows that perioperative CGM outperforms traditional tests in identifying frequent hyperglycemia and glycemic variability in the first weeks after transplantation, enabling enhanced glycemic control and improving the recipient\u2019s clinical outcome. Studies demonstrate higher glucose variability in kidney only recipients compared to other organ recipients, and in type 2 diabetes patients compared to those with PTDM. Poor perioperative glycemic control and glycemic variability detected by CGM have been linked to acute rejection and reduced graft survival. CGM-derived metrics outperform conventional glucose measures in predicting PTDM. CGM metric thresholds within the first month post-transplant achieved sensitivities above 85% and specificities up to 83% for PTDM risk. CGM-guided adjustment of immunosuppressants and steroid dosing have been shown to reduce hyperglycemia and variability. Comparative studies indicate that glycosylated hemoglobin A1c correlates poorly with CGM in the early post-transplant period, often misclassifying patients as normoglycemic. CGM appears to offer clinically relevant insights for the early detection, prediction, and management of dysglycemia in kidney transplant recipients.<\/jats:p>","DOI":"10.1186\/s12882-025-04691-2","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:47:58Z","timestamp":1766036878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Continuous glucose monitoring in kidney transplant recipients: a narrative review"],"prefix":"10.1186","volume":"27","author":[{"given":"Khaled","family":"Oweidat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C. T.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"5","key":"4691_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2337\/cd20-0043","volume":"38","author":"EM Miller","year":"2020","unstructured":"Miller EM. Using continuous glucose monitoring in clinical practice. Clin Diabetes. 2020;38(5):429\u201338.","journal-title":"Clin Diabetes"},{"issue":"12","key":"4691_CR2","first-page":"12","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia 2022. 2022;65(12):12.","journal-title":"Diabetologia 2022"},{"issue":"3","key":"4691_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/clinem\/dgac601","volume":"108","author":"VD Torres Roldan","year":"2023","unstructured":"Torres Roldan VD, Urtecho M, Nayfeh T, Firwana M, Muthusamy K, Hasan B, et al. A systematic review supporting the endocrine society guidelines: management of diabetes and high risk of hypoglycemia. J Clin Endocrinol Metab. 2023;108(3):592\u2013603.","journal-title":"J Clin Endocrinol Metab"},{"key":"4691_CR4","unstructured":"Eurotransplant International Foundation. Annual Report Annual Report 2023. 2024 May."},{"issue":"6","key":"4691_CR5","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/ndt\/gfac333","volume":"38","author":"R Boenink","year":"2023","unstructured":"Boenink R, Kramer A, Tuinhout RE, Savoye E, \u00c5sberg A, Idrizi A, et al. Trends in kidney transplantation rate across europe: a study from the ERA registry. Nephrol Dialysis Transplantation. 2023;38(6):1528\u201339.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"6","key":"4691_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/TP.0000000000003943","volume":"106","author":"D Mudiayi","year":"2022","unstructured":"Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M, et al. Global estimates of capacity for kidney transplantation in world countries and regions. Transplantation. 2022;106(6):1113\u201322.","journal-title":"Transplantation"},{"key":"4691_CR7","doi-asserted-by":"publisher","first-page":"205435812092262","DOI":"10.1177\/2054358120922628","volume":"7","author":"D Chan Chun Kong","year":"2020","unstructured":"Chan Chun Kong D, Akbari A, Malcolm J, Doyle MA, Hoar S. Determinants of poor glycemic control in patients with kidney transplants: A Single-Center retrospective cohort study in Canada. Can J Kidney Health Dis. 2020;7:2054358120922628.","journal-title":"Can J Kidney Health Dis"},{"issue":"4","key":"4691_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2337\/dc18-1936","volume":"42","author":"M Coemans","year":"2019","unstructured":"Coemans M, Loon E, Van, Lerut E, Gillard P, Sprangers B, Senev A, et al. Occurrence of diabetic nephropathy after renal transplantation despite intensive glycemic control: an observational cohort study. Diabetes Care. 2019;42(4):625\u201334.","journal-title":"Diabetes Care"},{"key":"4691_CR9","doi-asserted-by":"crossref","unstructured":"Guthoff M, Vosseler D, Langanke J, Nadalin S, K\u00f6nigsrainer A, H\u00e4ring HU et al. Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach. Eckel J, editor. PLoS One. 2015;10(9):e0134971.","DOI":"10.1371\/journal.pone.0134971"},{"issue":"1","key":"4691_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/tri.13783","volume":"34","author":"M Hecking","year":"2020","unstructured":"Hecking M, Sharif A, Eller K, Jenssen T. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics. Transpl Int. 2020;34(1):27\u201348.","journal-title":"Transpl Int"},{"issue":"11","key":"4691_CR11","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/j.1600-6143.2004.00591.x","volume":"4","author":"S Gourishankar","year":"2004","unstructured":"Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am J Transplant. 2004;4(11):1876\u201382.","journal-title":"Am J Transplant"},{"issue":"7","key":"4691_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/01.TP.0000176482.63122.03","volume":"80","author":"E Sulanc","year":"2005","unstructured":"Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB. New-Onset diabetes after kidney transplantation: an application of 2003 international guidelines. Transplantation. 2005;80(7):945\u201352.","journal-title":"Transplantation"},{"key":"4691_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijsu.2017.12.037","volume":"51","author":"Jlin Song","year":"2018","unstructured":"Song Jlin, Li M, Yan LN, Yang JY, Yang J, Jiang L. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation. Int J Surg. 2018;51:17\u201323.","journal-title":"Int J Surg"},{"key":"4691_CR14","doi-asserted-by":"crossref","unstructured":"Rashid R, Chaudhry D, Evison F, Sharif A. Mortality risk for kidney transplant candidates with diabetes: a population cohort study. Diabetologia. 2024.","DOI":"10.1007\/s00125-024-06245-x"},{"key":"4691_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8735782","volume":"2016","author":"A Sheu","year":"2016","unstructured":"Sheu A, Depczynski B, O\u2019Sullivan AJ, Luxton G, Mangos G. The effect of different glycaemic States on renal transplant outcomes. J Diabetes Res. 2016;2016:1\u20136.","journal-title":"J Diabetes Res"},{"key":"4691_CR16","doi-asserted-by":"crossref","unstructured":"Kim YC, Shin N, Lee S, Hyuk H, Kim YH, Kim H et al. Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: a multicenter cohort study in Korea. D\u2019Addio F, editor. PLoS One. 2018;13(4):e0195566.","DOI":"10.1371\/journal.pone.0195566"},{"issue":"10","key":"4691_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/ndt\/16.10.1978","volume":"16","author":"MC Thomas","year":"2001","unstructured":"Thomas MC, Mathew TH, Russ GR. Glycaemic control and graft loss following renal transplantation. Nephrol Dialysis Transplantation. 2001;16(10):1978\u201382.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"9","key":"4691_CR18","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1111\/ajt.12850","volume":"14","author":"A Sharif","year":"2014","unstructured":"Sharif A, Hecking M, De Vries APJ, Porrini E, Hornum M, Rasoul-Rockenschaub S, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transpl. 2014;14(9):1992\u20132000.","journal-title":"Am J Transpl"},{"key":"4691_CR19","doi-asserted-by":"crossref","unstructured":"Chowdhury TA, Wahba M, Mallik R, Peracha J, Patel D, De P et al. Association of British clinical diabetologists and renal association guidelines on the detection and management of diabetes post solid organ transplantation. Diabet Med. 2021;38(6).","DOI":"10.1111\/dme.14523"},{"issue":"8","key":"4691_CR20","doi-asserted-by":"publisher","first-page":"e3047","DOI":"10.1002\/dmrr.3047","volume":"34","author":"A Nusca","year":"2018","unstructured":"Nusca A, Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, et al. Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab Res Rev. 2018;34(8):e3047.","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"4691_CR21","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/dc15-1188","volume":"38","author":"C Gorst","year":"2015","unstructured":"Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, et al. Long-term glycemic variability and risk of adverse outcomes: A systematic review and Meta-analysis. Diabetes Care. 2015;38(12):2354\u201369.","journal-title":"Diabetes Care"},{"key":"4691_CR22","doi-asserted-by":"crossref","unstructured":"Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1).","DOI":"10.1186\/s12933-020-01200-7"},{"issue":"14","key":"4691_CR23","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681.","journal-title":"JAMA"},{"issue":"4","key":"4691_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","volume":"4","author":"O Heisel","year":"2004","unstructured":"Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and Meta-Analysis. Am J Transplant. 2004;4(4):583\u201395.","journal-title":"Am J Transplant"},{"issue":"9","key":"4691_CR25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/TP.0000000000002155","volume":"102","author":"LJ Aouad","year":"2018","unstructured":"Aouad LJ, Clayton P, Wyburn KR, Gracey DM, Chadban SJ. Evolution of glycemic control and variability after kidney transplant. Transplantation. 2018;102(9):1563.","journal-title":"Transplantation"},{"issue":"5","key":"4691_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/dia.2009.0157","volume":"12","author":"LM Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez LM, Knight RJ, Heptulla RA. Continuous glucose monitoring in subjects after simultaneous Pancreas-Kidney and Kidney-Alone transplantation. Diabetes Technol Ther. 2010;12(5):347\u201351.","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"4691_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jdiacomp.2015.07.014","volume":"29","author":"J Werzowa","year":"2015","unstructured":"Werzowa J, Pacini G, Hecking M, Fidler C, Haidinger M, Brath H, et al. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus. J Diabetes Complications. 2015;29(8):1211\u20136.","journal-title":"J Diabetes Complications"},{"issue":"9S","key":"4691_CR28","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1097\/01.tp.0000885484.75009.75","volume":"106","author":"EA Jo","year":"2022","unstructured":"Jo EA, Min S, Han A, Ha J, Woo HY, Cho A, et al. 215.15: perioperative changes in glycemic indices using continuous glucose monitoring in kidney transplantation recipients. Transplantation. 2022;106(9S):S47\u201347.","journal-title":"Transplantation"},{"issue":"9460","key":"4691_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0140-6736(05)17962-8","volume":"365","author":"AJ Krentz","year":"2005","unstructured":"Krentz AJ, Wheeler DC. New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet. 2005;365(9460):640\u20132.","journal-title":"Lancet"},{"issue":"9","key":"4691_CR30","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.transproceed.2021.09.001","volume":"53","author":"M Smyrli","year":"2021","unstructured":"Smyrli M, Smyrlis A, Tsouka G, Apostolou T, Vougas V. Risk factors of the development of diabetes mellitus after kidney transplantation. Transpl Proc. 2021;53(9):2782\u20135.","journal-title":"Transpl Proc"},{"key":"4691_CR31","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska K, Kukulski L, Wr\u00f3bel M, Przyby\u0142owski P, Zakliczy\u0144ski M, Strojek K. Prevalence and risk factors of New-Onset diabetes after transplantation (NODAT). Ann Transpl. 2020;25.","DOI":"10.12659\/AOT.926556"},{"key":"4691_CR32","doi-asserted-by":"crossref","unstructured":"Kasiske B, Zeier M, Chapman J, Craig J, Ekberg H, Garvey C et al. Kidney International advance online publication. Kidney Int [Internet]. 2009;77(4). Available from: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KITxpGL_summary.pdf","DOI":"10.1038\/ki.2009.377"},{"key":"4691_CR33","doi-asserted-by":"crossref","unstructured":"Haller MC, Royuela A, Nagler EV, Pascual J, Webster AC. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Reviews. 2016.","DOI":"10.1002\/14651858.CD005632.pub3"},{"issue":"7","key":"4691_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1111\/ajt.13710","volume":"16","author":"D Sawinski","year":"2016","unstructured":"Sawinski D, Trofe-Clark J, Leas B, Uhl S, Tuteja S, Kaczmarek JL, et al. Calcineurin inhibitor Minimization, Conversion, Withdrawal, and avoidance strategies in renal transplantation: A systematic review and Meta\u2010Analysis. Am J Transplant. 2016;16(7):2117\u201338.","journal-title":"Am J Transplant"},{"key":"4691_CR35","doi-asserted-by":"crossref","unstructured":"Shin J, Jo EA, Woo HY, Cho A, Ko M, Kim S et al. Perioperative glucose monitoring with continuous glucose monitors identifies risk factors for post-transplant diabetes mellitus in kidney transplant recipients. Sci Rep. 2024;14(1).","DOI":"10.1038\/s41598-024-72025-7"},{"issue":"1","key":"4691_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-023-03374-y","volume":"81","author":"L Wang","year":"2023","unstructured":"Wang L, Huang J, Li Y, Shi K, Gao S, Zhao W, et al. Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients. Endocrine. 2023;81(1):58\u201366.","journal-title":"Endocrine"},{"key":"4691_CR37","doi-asserted-by":"crossref","unstructured":"Eleftheriadis G, Naik MG, Osmanodja B, Liefeldt L, Choi M, Halleck F et al. Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation\u2014A prospective proof-of-concept study. Am J Transplant. 2024.","DOI":"10.3389\/ti.2024.13724"},{"issue":"5","key":"4691_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.diabet.2012.10.007","volume":"39","author":"A Wojtusciszyn","year":"2013","unstructured":"Wojtusciszyn A, Mourad G, Bringer J, Renard E. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and May herald post-transplantation diabetes mellitus and graft failure. Diabetes Metab. 2013;39(5):404\u201310.","journal-title":"Diabetes Metab"},{"issue":"3","key":"4691_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ndt\/gft377","volume":"29","author":"CJ Yates","year":"2013","unstructured":"Yates CJ, Fourlanos S, Colman PG, Cohney SJ. Divided dosing reduces prednisolone-induced hyperglycaemia and glycaemic variability: a randomized trial after kidney transplantation. Nephrol Dialysis Transplantation. 2013;29(3):698\u2013705.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"5","key":"4691_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/petr.12106","volume":"17","author":"K Pasti","year":"2013","unstructured":"Pasti K, Szabo AJ, Prokai A, Meszaros K, Peko N, Solyom R, et al. Continuous glucose monitoring system (CGMS) in kidney-transplanted children. Pediatr Transpl. 2013;17(5):454\u201360.","journal-title":"Pediatr Transpl"},{"key":"4691_CR41","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA Elsayed","year":"2023","unstructured":"Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in Diabetes\u20142023. Diabetes Care. 2023;46:S19\u201340.","journal-title":"Diabetes Care"},{"key":"4691_CR42","doi-asserted-by":"crossref","unstructured":"Agate W, Pham NYN, Roumelioti ME, Argyropoulos C. Glycemic control with continuous glucose monitoring in kidney transplant patients. J Am Soc Nephrol. 2022;33(975.).","DOI":"10.1681\/ASN.20223311S1975c"},{"key":"4691_CR43","doi-asserted-by":"crossref","unstructured":"Jandovitz N, George SJ, Abate M, Kressel AM, Bolognese AC, Lau L et al. A randomized trial of continuous glucose monitoring to improve post-transplant glycemic control. Clin Transpl. 2023;37(12).","DOI":"10.1111\/ctr.15139"},{"issue":"3","key":"4691_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/intqhc\/mzaf046","volume":"37","author":"MA Barchiesi","year":"2025","unstructured":"Barchiesi MA, Calabrese A, Costa R, Di Pillo F, D\u2019Uffizi A, Tiburzi L, et al. Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement. Int J Qual Health Care. 2025;37(3):46.","journal-title":"Int J Qual Health Care"},{"key":"4691_CR45","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1016\/j.hpb.2019.10.2315","volume":"21","author":"J Yang","year":"2019","unstructured":"Yang J, Do, Yu HC, Ahn SW, Hwang Hpil. Comparison of glycemic variability, assessed by continuous glucose monitoring system (CGMS) during early post-transplantation period, between the recipients of kidney and liver transplantation. HPB. 2019;21:S482\u2013482.","journal-title":"HPB"},{"key":"4691_CR46","first-page":"1","volume":"2019","author":"HY Jin","year":"2019","unstructured":"Jin HY, Lee KA, Kim YJ, Park TS, Lee S, Park SK, et al. The degree of hyperglycemia excursion in patients of kidney transplantation (KT) or liver transplantation (LT) assessed by continuous glucose monitoring (CGM): pilot study. J Diabetes Res. 2019;2019:1\u201310.","journal-title":"J Diabetes Res"},{"key":"4691_CR47","unstructured":"Werzowa J, Fidler C, Haidinger M, Hecking M, Resl M. Continuous glucose monitoring for the diagnosis of transplant-associated hyperglycemia and new-onset diabetes after transplantation. Eur Surg = Acta Chir Austriaca. 2012;44."},{"key":"4691_CR48","doi-asserted-by":"crossref","unstructured":"Clayton P, Lonergan G, Wyburn K, Chadban S. Glycaemic profile early after kidney transplantation: Highs, lows and diagnostic dilemmas. Transplantation. 2014;98.","DOI":"10.1097\/00007890-201407151-00290"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04691-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:30:22Z","timestamp":1769167822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04691-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04691-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}